capecitabine,etoposide iv,temozolomide
roche
['ecog,acrin,ea2142', 'ea2142']
ecog-acrin ea2142 trial: platetop vs temcap in g3 #nen; no differences found in pfs/os. maybe due to the significant proportion of well-dif g3 net (panc 42.9%; non-pan 22.2%)?. great discussion by #drlieu: platetop remains soc for poorly-dif g3 nec #asco22 
Consultant in Medical Oncology with expertise in HPB and Neuroendocrine Tumours. Fundación Jiménez Díaz University Hospital. #BiliaryTractTumor #NET